Voluntis

Voluntis: Revolutionizing Healthcare with Digital Therapeutics

In today's fast-paced world, technology has become an integral part of our lives. From smartphones to smart homes, we rely on technology to make our lives easier and more convenient. But did you know that technology can also revolutionize healthcare? That's where Voluntis comes in.

Voluntis is a digital therapeutics company that designs innovative solutions to help people self-manage their treatment and improve real-world outcomes. Founded in 2001, the company has been at the forefront of digital health for over two decades.

Digital therapeutics are evidence-based interventions delivered through software that can be used independently or alongside traditional medical treatments. They have been shown to improve patient outcomes by providing personalized support and guidance throughout the treatment journey.

Voluntis' digital therapeutics cover a wide range of therapeutic areas, including diabetes, oncology, neurology, cardiology, and respiratory diseases. Their solutions are designed to empower patients by giving them greater control over their treatment while also providing healthcare professionals with valuable insights into patient behavior and treatment efficacy.

One of Voluntis' flagship products is Insulia®, a prescription-only app for people with type 2 diabetes that provides personalized insulin dose recommendations based on blood glucose levels and other factors such as food intake and physical activity. Insulia® has been clinically proven to improve glycemic control while reducing hypoglycemia risk.

Another product is Oleena®, a digital therapeutic for breast cancer patients undergoing chemotherapy that helps manage symptoms such as nausea, fatigue, pain, anxiety, depression, and sleep disturbances. Oleena® uses cognitive-behavioral therapy techniques combined with mindfulness exercises to provide emotional support throughout the treatment journey.

Voluntis' solutions are not only beneficial for patients but also for healthcare providers who can use them to monitor patient progress remotely and adjust treatments accordingly. This reduces the burden on healthcare systems while improving patient outcomes.

In addition to its commercial products, Voluntis also collaborates with pharmaceutical companies on clinical trials aimed at evaluating the safety and efficacy of digital therapeutics in various therapeutic areas. The company has partnerships with leading pharmaceutical companies such as Roche Diabetes Care and AstraZeneca among others.

With its cutting-edge technology and commitment to improving patient outcomes through innovation in healthcare delivery models; Voluntis is poised for continued growth in this rapidly evolving industry.

Conclusion:

In conclusion; Voluntis is an innovative company dedicated towards revolutionizing healthcare through its state-of-the-art digital therapeutics solutions across multiple therapeutic areas including diabetes; oncology; neurology; cardiology; respiratory diseases among others.

Their products have been clinically proven effective in improving real-world outcomes by empowering patients through personalized support & guidance throughout their treatment journey.

Moreover; they collaborate closely with leading pharmaceutical companies worldwide which further strengthens their position as one of the most trusted names within this space.

Overall if you're looking for cutting-edge technological advancements within your medical care then look no further than Voluntis!